| Overview |
| bsm-63075r-rbitc-100ul |
| VEGFR2 Recombinant Antibody, RBITC Conjugated |
| IF |
| Human |
| Specifications |
| RBITC |
| Rabbit |
| KLH conjugated synthetic peptide derived from human VEGFR2 |
| Recombinant |
| IgG |
| Lot Dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 3791 |
| P35968 |
| Cytoplasm, Nucleus, Secreted, Cell membrane |
| Vascular endothelial growth factor receptor 2; KDR; VEGF Receptor 2; CD309; CD309 antigen; Fetal liver kinase 1; FLK-1; FLK1; Kinase insert domain receptor (a type III receptor tyrosine kinase); Kinase insert domain receptor; KRD1; Ly73; Protein tyrosine kinase receptor FLK1; Protein-tyrosine kinase receptor flk-1; Tyrosine kinase growth factor receptor; VEGFR 2; VEGFR; VEGFR-2; VGFR2_HUMAN. |
| Application Dilution |
| IF |
|
Powered by Bioz